Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
Engleman
Edgar G
EG
Department of Pathology, Stanford University School of Medicine, CA 94305, USA. edengleman@stanford.edu
Fong
Lawrence
L
D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000628:therapy*; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology* / Q000637:transplantation; D015234:HLA-A Antigens / Q000276:immunology; D006801:Humans; D016219:Immunotherapy, Adoptive; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000628:therapy*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D015234:HLA-A Antigens